Monogenic Autoinflammatory Syndromes
“Autoinflammatory syndromes” is the broad name given to a group of heritable conditions that initially consisted of a group of diseases termed hereditary periodic fever syndromes. Autoinflammatory syndrome is the preferred name for these conditions, because not all of the disorders that have been added to this class of inflammatory disorde rs present with periodic febrile episodes. In contrast to autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, autoanti-bodies and antigen-specific T cells do not play a role in the pathogenesis of the autoinflammatory syndromes. Although the term autoinflammatory syndrome is now commonly used to include polygenic diseases such as Behcet's syndrome, Still's disease, and even Type 2 diabetes, this chapter addresses the monogenic autoin-flammatory syndromes. These syndromes demonstrate a Mendelian inheritance pattern, and their genetic causes have been identified. The disorders typically present in childhood. The disorders are divided into different clinical syndromes that include mixtures of clinical manifestations in the joints, the bones, the skin, the abdomen, and the lymph nodes.
KeywordsFamilial Mediterranean Fever Pyoderma Gangrenosum Familial Mediterranean Fever Patient Chronic Recurrent Multifocal Osteomyelitis MEFV Gene
We would like to thank Dr. Daniel Kastner for sharing his expertise and suggestions for the myths and pearls in the FMF section.
- Aksentijevich I, Galon J, Soares M, et al The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet. 2001;69(2):301– 14PubMedCrossRefGoogle Scholar
- Aksentijevich I, Nowak M, Mallah M, et al De novo CIAS1 mutations, cytokine activation, and evidence for geneticheterogeneity in patients with neonatal-onset multisystem inflammatory disease. NOMID a new member of the expanding family of pyrin-associated autoin-flammatory diseases. Arthritis Rheum. 2002 46(12):3340ȓ8PubMedCrossRefGoogle Scholar
- Aksentijevich I, Torosyan Y, Samuels J, et al Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet. 1999;64(4):949– 62PubMedCrossRefGoogle Scholar
- Arostegui JI, Solis P, Aldea A, et al Etanercept plus colchicine treatment in a child with tumour necrosis factor receptor-associated periodic syndrome abolishes auto-inflammatory episodes without normalising the subclinical acute phase response. Eur J Pediatr. 2005;164(1):13– 6PubMedCrossRefGoogle Scholar
- Cortis E, DeBenedetti F, Insalaco A, Cioschi S, Muratori F, D' Urbano LE, Uqazio AG. Abnormal production of tumor necrosis factor (TNF) — alpha and clinical efficacy of the TNF inhibitor etan-ercept in a patient with PAPA syndrome [corrected]. J Pediatr. 2004;145(6): 851–5PubMedCrossRefGoogle Scholar
- Drenth JP, Haagsma CJ, van der Meer JW. Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore). 1994;73(3):133–44Google Scholar
- Eleftheriou G, Bacis G, Fiocchi R, et al Colchicine-induced toxicity in a heart transplant patient with chronic renal failure. Clin Toxicol (Phila). 2008;17:1–4Google Scholar
- Ferguson PJ, El-Shanti HI. Autoinflammatory bone disorders. Curr Opin Immunol. 2007;19:492–8Google Scholar
- Galon J, Aksentijevich I, McDermott MF, et al TNF receptor-associated periodic syndromes (TRAPS): Mutations in TNFR1 and early experience with Etanercept therapy. Faseb Journal. 2000;14(6): A1150Google Scholar
- Kastner D. Familial Mediterranean fever. In: Fauci A, Braunwald E, Kasper D, Hauser SL, Longo DL, Jameson L, Loscalzo J, editors. Harrison' s principle of internal medicine. 17th ed. USA: McGraw-Hill; 2008Google Scholar
- van der Hilst J, Bodar E, Barron K, et al Follow-up, clinical features, and quality of life in 10.3 patients with HyperImmunoglubulin D syndrome. Clin Exp Rheumatol. 2008;26(2):180Google Scholar
- Williamson LM, Hull D, Mehta R, et al Familial Hibernian fever. Q J Med. 1982;1(204):469–80Google Scholar